Cano Health

Cano Health, Inc. operates primary care centers and supports affiliated medical practices that engages in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico. It provides population health management tools including telehealth, prescription home delivery, wellness programs, transition of care, and high-risk and complex care management. The company was founded by Marlow Hernandez in 2009 and is headquartered in Miami, FL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Cano Health reports strong 2022 performance, eyes growth opportunities

Cano Health demonstrated strong performance in membership growth and revenue generation in 2022, despite facing challenges in revenue per member and goodwill impairment. Strategic actions to enhance liquidity and operational efficiency position the company for future growth.
The company's focus on optimizing operations, expanding strategically, and improving cash flows presents opportunities for sustainable growth and profitability. Renegotiated contracts and cost-saving initiatives aim to address challenges and drive financial performance.
With a clear roadmap for 2023, including membership and revenue targets, Cano Health is poised to capitalize on its strengths, navigate challenges, and leverage opportunities to drive value for stakeholders. The company's financial health and growth prospects remain promising.

Cano Health reports robust Q1 performance, focuses on profitability

Cano Health's Q1 2023 performance showcased strong revenue growth, membership expansion, and a focus on operational efficiency and profitability.
The company faces challenges in managing increased MCR and seasonality impacts but is strategically positioned to capitalize on opportunities for growth and cost optimization.
By divesting non-core assets, reallocating resources, and focusing on Medicare Advantage business, Cano Health aims to drive profitability and enhance shareholder value.
Overall, Cano Health's performance, strategic initiatives, and financial position indicate a positive outlook for continued growth and operational improvements.

Cano Health reports revenue growth but faces financial challenges in Q2 2023

Cano Health's Q2 2023 showcased revenue growth and membership expansion, but challenges with financial performance and liquidity require strategic focus.
The company's strengths in core markets and operational efficiency initiatives offer opportunities for growth and improved profitability.
Navigating challenges with Medicare Risk Adjustment, unexpected expenses, and market exits will be crucial for Cano Health's future success and financial stability.

Cano Health reports Q3 losses, focuses on cost management strategies

Cano Health's Q3 2023 performance reflects a mix of challenges and strengths, with a focus on cost management and operational efficiency.
The company's strategic initiatives in the Medicare Advantage business show promise for revenue growth and cost reductions.
While facing liquidity concerns and financial losses, Cano Health is actively addressing these challenges through restructuring and cost-saving measures.
Opportunities for growth and improved financial performance exist through further cost optimization and strategic decision-making.

Cano Petroleum, Inc. operates as an independent oil and natural gas company. The company was founded by Jeffery S. Johnson in 1997 and is headquartered in Tulsa, OK.

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI , June 16, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a change in its executive leadership intended to advance execution of the Company's strategy for stockholder value creation. Effective immediately, the Company has named current Chief Strategy Officer Mark Kent as Interim Chief Executive Officer while an external search is conducted for a permanent successor.

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO) and collectively represent the largest single stockholder of the Company, today announced that its proxy solicitor's analysis of preliminary results indicates more than 75% of the votes cast WITHHELD support f.

Concerned Shareholders of Cano Health Obtain Clear Referendum for Change at 2023 Annual Meeting

Dr. Alan Muney and Kim Rivera re-elected to Board of Directors MIAMI , June 15, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced the results of its Annual Stockholders' Meeting (the "Annual Meeting"). Based on the vote tabulation by the Company's proxy solicitor, Cano Health's two director nominees, Dr. Alan Muney and Kim Rivera, have been re-elected to the Company's Board of Directors.

Cano Health Announces Results of Annual Stockholders' Meeting

Court rejects former directors' attempt to delay meeting MIAMI , June 15, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today confirmed that it will proceed with its Annual Meeting today, June 15, 2023, at 1:00 pm ET. Cano Health is gratified the Delaware Court of Chancery agreed with its position and rejected the former directors' attempt to re-open the Company's nomination window.

Cano Health to Proceed with Today's Annual Stockholders' Meeting

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO) and collectively own an approximately 35% equity stake in the Company, today issued the following statement in relation to the Company's 2023 Annual Meeting of Stockholders (the “Annual Meeting”) scheduled to.

Concerned Shareholders of Cano Health Reiterate the Need for Changes in Leadership and Strategy at the Company Following Massive Value Destruction

Cano Health is a beaten-down Health Care Facilities name with a concerning capital position. Free cash flow is expected to turn positive, however, and an important shareholder meeting could move the stock later this month. I have a buy rating for Cano Health on valuation and note important technical levels to monitor.

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Board and management are evolving governance practices and executing an action plan to drive long-term sustainable growth and value creation for ALL stockholders In contrast, former directors are intent on conducting a disruptive, misleading, and disingenuous campaign aimed only at serving their own short-term interests MIAMI , June 8, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today sent a letter to stockholders in connection with its June 15, 2023 Annual Meeting. The Company's Board of Directors unanimously recommended that stockholders vote the WHITE Proxy Card "FOR" the re-election of its highly qualified, independent directors and the proposed reverse stock split.

Cano Health Sends Letter to Stockholders and Urges Stockholders to Vote the WHITE Proxy Card "FOR" Its Highly Qualified Directors and the Proposed Reverse Stock Split

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO) and collectively own an approximately 35% equity stake in the Company, today announced that both leading independent proxy advisory firms – Institutional Shareholder Services, Inc. (“ISS”) and Glass, Lewis &am.

ISS and Glass Lewis Recommend Cano Health Stockholders WITHHOLD on Incumbent Directors Dr. Alan Muney and Kim Rivera

Cano Health's directors standing for re-election bring world-class backgrounds and relevant expertise to effectively oversee the Company's action plan ISS and Glass Lewis recommend stockholders vote "FOR" the Company's proposed reverse stock split MIAMI , June 7, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today issued the following statement commenting on the reports issued by Institutional Shareholder Services ("ISS") and Glass Lewis regarding the Company's June 15, 2023 Annual Stockholders' Meeting: The Company appreciates ISS and Glass Lewis' agreement that the proposed reverse stock split is in the best interests of stockholders, and their recommendation to vote "FOR" the proposed reverse stock split. However, the Company strongly disagrees with the recommendations to withhold votes from Dr. Alan Muney and Kim Rivera.

Cano Health Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote "FOR" Re-Election of Its Highly Qualified, Independent Directors

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht today released the following letter to Cano Health, Inc. (NYSE: CANO) stockholders: Fellow Stockholder, The three of us – Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with our affiliates, the “Group” or “we”) – hold an approximately 35% equity stake in Cano Health, Inc. (“Cano” or the “Company”), making our Group the largest stockholder of the Company. The three of us served on Cano's Boa.

Concerned Shareholders of Cano Health Issue Letter Regarding its Commitment to Turning Around the Company

MIAMI , May 31, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced the appointment of Frederick S. Green as its Interim Chief Legal Officer, effective immediately.

Cano Health Appoints Frederick Green as Interim Chief Legal Officer

Draws a sharp contrast between the Board and management's clear long-term stockholder value creation plan and the former directors' short-term, self-interested agenda Urges stockholders to vote on the WHITE proxy card "FOR" re-election of the Company's directors and the proposed reverse stock split MIAMI , May 31, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has published an investor presentation to its investor relations website in connection with its upcoming Annual Stockholders' Meeting (the "Annual Meeting"), scheduled for June 15, 2023. The presentation is also being filed with the U.S. Securities and Exchange Commission.

Cano Health Highlights Long-Term Value Creation Strategy in New Investor Presentation

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group,” “us” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today announced that they have issued a presentation that outlines the urgent case for changes in leadership and strategy at the Company. The Group, which holds an approximately 35% equity stake in Cano.

Concerned Shareholders of Cano Health Issue Presentation to Underscore the Urgent Need for Changes in Leadership and Strategy Following Massive Value Destruction at the Company

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group,” “us” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today announced that they have filed a definitive proxy statement with the U.S. Securities and Exchange Commission in order to solicit WITHHOLD votes against the re-election of Dr. Alan Muney, Chair of.

Concerned Shareholders of Cano Health File Definitive Proxy Statement to Solicit Votes Against the Company's Two Entrenched Director Candidates

Board and management remain laser focused on executing their action plan to drive long-term sustainable growth and value creation Former directors' misleading and disruptive campaign serves only their short-term agenda and undermines long-term interests of all shareholders Urges shareholders to vote on Cano Health's WHITE proxy card in favor of the Company's directors and the proposed reverse stock split MIAMI , May 22, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission and sent a letter to shareholders in connection with its upcoming Annual Stockholders' Meeting (the "Annual Meeting"), which is scheduled for June 15, 2023. The Cano Health Board of Directors unanimously recommends that shareholders vote "FOR" each of the proposals listed on the WHITE proxy card enclosed with the definitive proxy statement—including the re-election of Dr. Alan Muney and Kim M.

Cano Health Files Definitive Proxy Statement and Sends Letter to Shareholders

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group,” “us” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today announced that they have submitted a notice to the Company to nominate two highly qualified, independent candidates – Joseph Berardo, Jr. and Guy P. Sansone – for election to the Board of Director.

Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. Marlow Hernandez from Board for Cause

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group”, “us” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today issued the below letter to shareholders regarding its intended efforts at the 2023 Annual Meeting of Shareholders (the “Annual Meeting”). *** Fellow Shareholders, Cano's upcoming Annual Meeting pr.

Concerned Shareholders of Cano Health Launch Director Withhold Campaign at the Company's 2023 Annual Meeting

Cano Health, Inc. (NYSE:CANO ) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Marlow Hernandez - Chief Executive Officer Mark Kent - Chief Strategy Officer Bob Camerlinck - Chief Operating Officer Brian Koppy - Chief Financial Officer Conference Call Participants Ben Rosssi - Citi Jailendra Singh - Truist Securities Brian Tanquilut - Jefferies A.J. Rice - Credit Suisse Operator Please standby.

Cano Health, Inc. (CANO) Q1 2023 Earnings Call Transcript

Cano Health, Inc. (CANO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.07 per share a year ago.

Cano Health, Inc. (CANO) Reports Q1 Loss, Tops Revenue Estimates

Raises guidance for full year 2023 membership and total revenue; maintains outlook for medical cost ratio and Adjusted EBITDA Pursuing divestiture of certain non-core assets to strengthen its focus on high-performing Medicare Advantage business MIAMI , May 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial Results Total membership of 388,667 including 207,420 Medicare capitated members, an increase of 44% and 29% year-over-year, respectively Total revenue of $866.9 million, compared to $704.3 million the prior year, an increase of 23% year-over-year Net loss of $(60.6) million, compared to a net loss of $(0.1) million in the prior year, primarily driven by a higher operating loss, the change in fair value of warrant liabilities, and higher interest expense Adjusted EBITDA1 of $5.0 million, compared to $29.2 million in the prior year In the first quarter of 2023, capitated revenue of $841.1 million increased 25% year-over-year.

Cano Health Announces Financial Results for the First Quarter 2023

Cano Health, Inc. (CANO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cano Health, Inc. (CANO) Expected to Beat Earnings Estimates: Should You Buy?

NEW YORK & MIAMI--(BUSINESS WIRE)--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the “Group” or “we”), who recently resigned as members of the Board of Directors (the “Board”) of Cano Health, Inc. (“Cano” or the “Company”) (NYSE: CANO), today issued the below letter to shareholders. *** Fellow Shareholders, Our group, which collectively holds an approximately 36% equity position in Cano, is writing in response to the Company's April 17th ann.

Concerned Shareholders of Cano Health Issue Open Letter Regarding the Board's Entrenchment Maneuvers and Latest Governance Failures

MIAMI , April 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.  To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health First Quarter 2023 Earnings Conference Call and Conference ID 8371699.

Cano Health Announces Date to Report First Quarter 2023 Results

Agilon Health

Humana

Viatris

Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (AGL) and Cano Health (CANO).

4 Healthcare Stocks Poised to Beat Q1 Earnings Estimates

Facilities to Deliver Health & Wellness Offerings for the Senior Community Facilities to Deliver Health & Wellness Offerings for the Senior Community

News for Cano Health Stock (CANO)